Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.75 USD | -4.32% | -3.85% | +54.38% |
09/05 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.38% | 535.97Cr | |
+8.29% | 11TCr | |
+10.21% | 10TCr | |
-11.90% | 2.24TCr | |
+0.49% | 2.23TCr | |
-5.57% | 1.91TCr | |
-37.36% | 1.8TCr | |
-5.17% | 1.79TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- ImmunityBio Resubmits Biologics License Application for Bladder Cancer Combination Therapy